These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33842719)

  • 21. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
    Gauthier-Loiselle M; Cloutier M; Toro W; Patel A; Shi S; Davidson M; Bischof M; LaMarca N; Dabbous O
    Adv Ther; 2021 Dec; 38(12):5809-5828. PubMed ID: 34713391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach.
    Bortolani S; Stura G; Ventilii G; Vercelli L; Rolle E; Ricci F; Bergui M; Mongini T
    Neuromuscul Disord; 2019 Oct; 29(10):742-746. PubMed ID: 31604650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anesthetic management of pediatric patients undergoing intrathecal nusinersen administration for treatment of spinal muscular atrophy: A single-center experience.
    Brollier LD; Matuszczak M; Marri T; Carbajal JG; Moorman AT; Sorial EM; Jain R
    Paediatr Anaesth; 2021 Feb; 31(2):160-166. PubMed ID: 32623818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy.
    Cordts I; Lingor P; Friedrich B; Pernpeintner V; Zimmer C; Deschauer M; Maegerlein C
    Ther Adv Neurol Disord; 2020; 13():1756286419887616. PubMed ID: 32010224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy.
    Stolte B; Totzeck A; Kizina K; Bolz S; Pietruck L; Mönninghoff C; Guberina N; Oldenburg D; Forsting M; Kleinschnitz C; Hagenacker T
    Ther Adv Neurol Disord; 2018; 11():1756286418803246. PubMed ID: 30305849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
    Wurster CD; Winter B; Wollinsky K; Ludolph AC; Uzelac Z; Witzel S; Schocke M; Schneider R; Kocak T
    J Neurol; 2019 Jan; 266(1):183-194. PubMed ID: 30460449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery.
    Mendonça RH; Fernandes HDS; Pinto RBS; Matsui Júnior C; Polido GJ; Silva AMSD; Grossklauss LF; Reed UC; Zanoteli E
    Arq Neuropsiquiatr; 2021 Feb; 79(2):127-132. PubMed ID: 33759979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforaminal intrathecal delivery of nusinersen for older children and adults with spinal muscular atrophy and complex spinal anatomy: an analysis of 200 consecutive injections.
    Weaver JJ; Hallam DK; Chick JFB; Vaidya S; Shin DS; Natarajan N; Rad N; Reis J; Koo KSH; Shivaram GM; Thibodeau A; Apkon S; Monroe EJ
    J Neurointerv Surg; 2021 Jan; 13(1):75-78. PubMed ID: 32471828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of nusinersen via paramedian approach for spinal muscular atrophy.
    Iwayama H; Wakao N; Kurahashi H; Kubota N; Hattori A; Kumagai T; Okumura A
    Brain Dev; 2021 Jan; 43(1):121-126. PubMed ID: 32773161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cone-beam computed tomography guided nusinersen administrations in adult spinal muscular atrophy patients with challenging access: a single- center experience.
    Salapura V; Snoj Z; Leonardis L; Koritnik B; Kostadinova V
    Radiol Oncol; 2022 Aug; 56(3):319-325. PubMed ID: 35962954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Spinal Surgery on Intrathecal Nusinersen Injections in Pediatric Spinal Muscular Atrophy.
    Aksoy T; Ramazanov R; Öz Yildiz S; Demirkiran G; Haliloğlu G; Yazici M
    J Pediatr Orthop; 2024 Aug; 44(7):e641-e646. PubMed ID: 38888134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound assisted lumbar intrathecal administration of nusinersen in adult patients with spinal muscular atrophy: A case series.
    Zanfini BA; Catarci S; Patanella AK; Pane M; Frassanito L; Filipponi E; Mercuri E; Sabatelli M; Draisci G
    Muscle Nerve; 2021 Nov; 64(5):594-599. PubMed ID: 34396547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug treatment for spinal muscular atrophy type I.
    Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD006281. PubMed ID: 31825542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforaminal intrathecal delivery of nusinersen using cone-beam computed tomography for children with spinal muscular atrophy and extensive surgical instrumentation: early results of technical success and safety.
    Weaver JJ; Natarajan N; Shaw DWW; Apkon SD; Koo KSH; Shivaram GM; Monroe EJ
    Pediatr Radiol; 2018 Mar; 48(3):392-397. PubMed ID: 29130140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomography-guided transforaminal lumbar puncture using local anesthesia and a straight 22-gauge spinal needle for intrathecal nusinersen in adults: Findings in 77 procedures.
    Cox M; Atsina KB; Ramchand P; Ji J; Sedora-Roman N; Pukenas B
    Interv Neuroradiol; 2022 Jun; 28(3):262-265. PubMed ID: 34424100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis.
    Fox D; To TM; Seetasith A; Patel AM; Iannaccone ST
    Adv Ther; 2023 Mar; 40(3):903-919. PubMed ID: 36534265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Needleless inhaled anesthesia with sevoflurane: Advantages of a simplified approach for children with spinal muscular atrophy undergoing intrathecal administration of nusinersen.
    Salerno A; Picconi E; Genovese O; Piastra M; Pulitanò SM; Tosi F; Mancino A; Pane M; De Sanctis R; Carlini D; Mercuri EM; Conti G
    Paediatr Anaesth; 2023 Apr; 33(4):282-290. PubMed ID: 36636888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Symptomatic Spinal Muscular Atrophy with Nusinersen: A Prospective Longitudinal Study on Scoliosis Progression.
    Ip HNH; Yu MKL; Wong WHS; Liu A; Kwan KYH; Chan SHS
    J Neuromuscul Dis; 2024; 11(2):349-359. PubMed ID: 38363614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy.
    Kizina K; Stolte B; Totzeck A; Bolz S; Fleischer M; Mönninghoff C; Guberina N; Oldenburg D; Forsting M; Kleinschnitz C; Hagenacker T
    Front Neurol; 2019; 10():1166. PubMed ID: 31787921
    [No Abstract]   [Full Text] [Related]  

  • 40. The Complex Spine in Children with Spinal Muscular Atrophy: The Transforaminal Approach-A Transformative Technique.
    Towbin R; Schaefer C; Kaye R; Abruzzo T; Aria DJ
    AJNR Am J Neuroradiol; 2019 Aug; 40(8):1422-1426. PubMed ID: 31296522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.